O24367 AF NFT

Pleiotropic drug resistance protein TUR2

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeidb3ei2dqe77ke6pt6rltb2mjykjw7pq2r2zepehlqf7is2ga5xfe/metadata.json
IPFS of structure file: 
bafybeiciixvql5blq4ifnkylkd7renaiif57oh6bslcx23y4bm2odxthhi/AF-O24367-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xF8cD1d8d93E9783063700De244A6e3cf6A195579
First NFT owner address (bech32): 
genesis1lrx3mrvna9urqcmsph3yffhrea4pj4tedrk7yh
Current NFT ID #482108 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
482108
Accession (UniProt):
O24367
Name::
Pleiotropic drug resistance protein TUR2
Experimental Method:
Predicted structure
Sequence source:
Spirodela polyrhiza

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT O24367 research and analysis (ICN3D with VR)

FASTA sequences

>sp|O24367|TUR2_SPIPO Pleiotropic drug resistance protein TUR2 OS=Spirodela polyrhiza OX=29656 GN=TUR2 PE=1 SV=1 MEIAGYRGGSLRGSLQGSLRRSVSAWRSPSTSDVFGRSSREEDDEEALKWAALEKLPTYDRLRKGIMTGDGGEIQEVDIQGLGFQERKNLLEKLVRNAEEDNERFLLKLRNRMERVGIDNPTIEVRFEHLNINAEAFVGNRGVPTLVNFFVNKAIWILSALHLMPSGKRPISILHDVSGIIKPCRMTLLLGPPGAGKTTLLLALAGKLDNTLKVTGNVTYNGHGMHEFVPQRTSAYISQHDVHIGEMTVRETLAFSSRCQGVGTRYEMLTELSRREKEANIKPDPDVDVYMKAVAVEGQESVVTDYILKILGLDICADTMVGDGMIRGISGGQKKRVTTGEMLVGPSKALFMDEISTGLDSSTTFQIVNSLRQSVHILGGTALIALLQPAPETYDLFDDILLLSDGQIVYQGPRENVLEFFESMGFKCPERKGVADFLQEVTSRKDQQQYWVRENEPYRFVPVNEFSEAFKSFHVGAKLHEELSTPFDRSRNHPAALTTSKYGISKMELLKACIDREWLLMKRNSFVYIFKVVQLIVLALIAMTVFFRTKLPRNGLEDATIFFGAMFLGLVTHLFNGFAELAMSIAKLPVFYKQRDLLFYPPWAYALPTWILKIPISFVECGVWIAMTYYVIGFDPNVVRMFRHYLLLVLISQVASGLFRLLAAVGRDMVVADTFGAFAQLVLLVLGGFIIAREKIKKFWIWGYWSSPLMYAQNAIAVNEFLGHSWNKLVDATGQTLGERFLRNRGIFVDKNWYWIGVGALIGYMVLFNFLFILFLEWLDPLGKGQTTVSEEALQEKEANRTGANVELATRGSAATSDGGSVEIRKDGNRKKGMVLPFTPLSITFDNVKYSVDMPQEMKDRGVTEDKLLLLKGVSGAFRPGVLTALMGVSGRGKTTLMDVLAGRKTGGYIEGDIRISGYPKNQETFARISGYCEQNDIHSPHVTVYESLLYSAWLRLPAEVDEKQRKMFVDEVMDLVELNSLRGSLVGLPGVTGLSTEQRKRLTIAVELVANPSIIFMDEPTSGLDARAAAIVMRAVRNTVDTGRTVVCTIHQPSIDIFEAFDELFLMKRGGEEIYVGPLGRQSSHLIKYFESIDGVKKIKERYNPATWMLEVTTISQEEILGLNFAEVYRNSDLYKRNKDLIKELSTPPPGSKDLFFATQFSQSFVMQCLACLWKQHKSYWRNPSYTATRLFFTVVIALIFGTIFWDLGKKRSTSLDLINAMGSMYAAVLFIGIQNAQTVQPIVDVERTVFYREKAAGMYSALPYAYAQVLIEVPHILVQTLLYGLLVYSMIGFDWTAAKFLWYMFFMFFTFLYFTYYGMMAVAMTPNSDIAAIVAAAFYAIWNIFAGFIIPRPRIPIWWRWYYWACPVAWTLYGLVVSQFGEYTDTMSDVDETVKDFLRRFLGFRHDFLPVVGVMVVVFTVLFASIFAFSIKTLNFQRR